Medicare
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029.
The CMS Nov. 4 issued a final rule that updates physician fee schedule payments for calendar year 2027.
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees that continue on the same plans, according to a KFF analysis released Oct. 30. Monthly premiums for Medicare Advantage prescription drug…
The undersigned strongly urge CMMI to delay Ambulatory Specialty Model (ASM)’s launch until all operational and technical infrastructure is available, tested, and ready for the model to start.
CMS recently engaged a third-party audit firm, Myers & Stauffer, to review and audit Medicare cost report data pertaining to selected cost issues.
AHA comments on the CMS Preliminary CY 2027 Medicare Clinical Laboratory Fee Schedule Rates and accompanying documents released on Sept. 21, 2026.
The Centers for Medicare & Medicaid Services announced that it will exercise enforcement discretion for inpatient rehabilitation facility admissions from Oct. 1, 2026 through March 31, 2027, with respect to the timing of the initial interdisciplinary team meeting requirement.
AHA Comments to MedPAC on MA Beneficiaries' Post-acute Care Service Utilization.
The Centers for Medicare & Medicaid Services announced Sept. 25 that it will expand the Inpatient Rehabilitation Facility Review Choice Demonstration to include all IRFs that bill Medicare Administrative Contractor Jurisdiction J, which generally includes Alabama, Georgia and Tennessee.
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to individuals with Original Medicare.